期刊文献+

202例NIPT高风险孕妇羊水细胞染色体核型分析 被引量:5

Amniotic fluid chromosome analysis for 202 noninvasive prenatal testing high risks pregnant
原文传递
导出
摘要 目的验证无创DNA产前检测(NIPT)技术提示非整倍染色体异常的准确性。方法对厦门市妇幼保健院202例NIPT提示高风险孕妇羊水细胞染色体核型进行比对分析。结果 202例NIPT高风险孕妇羊水染色体核型异常共125例,其中21-三体阳性预测值最高(91.25%),其次是18-三体(57.89%)和性染色体异常(55.35%),阳性预测值最低的是13-三体(25%)。结论 NIPT技术对21-三体阳性预测值很高,具有一定的临床应用价值,可作为传统产前筛查技术的辅助手段。 Objective:To explore the accuracy of noninvasive prenatal testing(NIPT)technology in prenatal screening. Methods:Amniotic fluid chromosomes of 202 NIPT high risk pregnant women in center of prenatal diagnosis of maternal and child health care hospital of Xiamen were analyzed. Results:Analysis of amniotic fluid chromosome karyotypes showed there are 125 abnormalities in 202 cases of NIPT high risk pregnant women. The highest positive predictive value of NIPT was for trisomy 21(91.25%),Secondary is trisomy 18(57.89%),Then sex chromosome abnormalities(55.35%),the lowest positive detection rate is trisomy13(25%). Conclusion:NIPT technology has a high detection rate of trisomy 21,which can be used as an auxiliary means of traditional prenatal screening technology.
作者 陈小露 葛运生 郭奇伟 陈佳燕 蔡美娇 CHEN Xiao-lu;GE Yun-sheng;GUO Qi-wei;CHEN Jia-yan;CAI Mei-jiao(Center of Prenatal Diagnosis of Maternal and Child Health Care Hospital of Xiamen,Xiamen 361000,China)
出处 《中国优生与遗传杂志》 2018年第8期34-36,共3页 Chinese Journal of Birth Health & Heredity
关键词 产前筛查 染色体核型分析 无创DNA产前检测 21-三体综合征 Prenatal screening Chromosome karyotype analysis Noninvasive prenatal testing trisomy 21
  • 相关文献

参考文献4

二级参考文献33

  • 1柳爱华,宋奉侠,郝明革,孙文芝,冯光,储穆庭,张莉.母血清筛查21-三体、18-三体高风险病例的产前诊断[J].中国产前诊断杂志(电子版),2012,4(2):8-10. 被引量:17
  • 2Tabor A,Vestergaard CH,Lidegaard F,et al.Lost rate after chorionic villus sampling and amniocentesis:an 11-year national registry study[J].Ultrasound Obstet Gynecol,2009,34(1):19-24.
  • 3Franssen MT,Korevaar JC,Tjoa WM,et al.Inherited unbalanced structural chromosome abnormalities at prenatal chromosome analysis are rarely ascertained through recurrent miscarriage[J].Prenat Diagn,2008,28(5):408-411.
  • 4Wald NJ,Kennard A,Hackshaw A,et al.Antenatalscreening for Down's syndrome[J].J Med Semen,1997,4:181-246.
  • 5Summers AM.Maternal serum screening in ontario using the tripiemarkertest[J].J Med Screen,2003,10:107-111.
  • 6Lo YM,Corbetta N,Chamberlain PF,et al.Presence of fetal DNA in maternal plasma and serum[J].Lancet,1997,350(9 076):485-487.
  • 7Lo YM,Tein MS,Lau TK,et al.Quantitative analysis of fetal DNA in maternal Plasma and serum:Implications for noninvasive prenatal diagnosis[J].Am J Hum Genet,1998,62(4):768-775.
  • 8Lun FM,Chiu RW,Allen CK,et al.Microfluidics digital PCR reveals a higher than expected fraction of fetal DNA in maternal plasma[J].Clin Chem,2008,54(10):1664-1672.
  • 9Chin RW,Chan KC,Gao Y,et al.Noninvasive prenatal diagnosis of fetal chromosomal aneuploidy by massively parallel genomic sequencing of DNA in maternal plasma[J].Proc Natl Acad Sci USA,2008,105:20 458-20 463.
  • 10Lo YM,Chan KC,Sun H,et al.Maternal plasma DNA sequencing reveals the genome-wide genetic and mutational profile of the fetus[J].Sci Transl Med,2010,2(61):61-91.

共引文献37

同被引文献32

引证文献5

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部